Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2019 08:30 ET | Source: iBio, Inc.

iBio Announces Appointment of Thomas F. Isett to Board of Directors

NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a biologics contract manufacturer and product developer with proprietary, “green” technologies for biopharmaceutical...
December 14, 2018 08:00 ET | Source: iBio, Inc.

iBio Provides Status Update on its Continuing Litigation Against Fraunhofer

NEW YORK, Dec. 14, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a developer and manufacturer of biotherapeutics, announced today that the Second Complaint it filed in iBio’s litigation...
December 03, 2018 08:00 ET | Source: iBio, Inc.

iBio to Present at Brazilian Ministry of Health’s Plant-Made Pharmaceutical Meeting

NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a developer and manufacturer of biotherapeutics, today announced that it will present at the Plant-Based Technology...
October 02, 2018 08:00 ET | Source: iBio, Inc.

iBio and CC-Pharming Hold First Design and Strategy Meeting

NEW YORK, Oct. 02, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced the beginning of a four-day design and strategic planning meeting with executives and technical experts...
August 22, 2018 16:10 ET | Source: iBio, Inc.

iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance

NEW YORK, Aug. 22, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN: IBIO) (“IBIO” OR THE “COMPANY”), today announced that NYSE Regulation has accepted the Company’s plan to regain compliance with...
July 09, 2018 08:00 ET | Source: iBio, Inc.

iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China

NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced the commencement of a strategic commercial relationship with CC-Pharming Ltd. of Beijing, China for joint...
June 26, 2018 18:59 ET | Source: iBio, Inc.

iBio, Inc. Closes $16,000,000 Public Offering

NEW YORK, June 26, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“IBIO” OR THE “COMPANY”), today announced that it has closed its previously announced underwritten public offering with...
June 22, 2018 07:26 ET | Source: iBio, Inc.

iBio, Inc. Prices $16,000,000 Public Offering

NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” OR THE “COMPANY”), today announced the pricing of an underwritten public offering with expected total gross...
June 08, 2018 16:30 ET | Source: iBio, Inc.

iBio, Inc. Announces Completion of 1-For-10 Reverse Stock Split

NEW YORK, June 08, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“IBIO” OR THE “COMPANY”) announced today that its previously announced 1-for-10 reverse stock split of common stock...
June 08, 2018 16:01 ET | Source: iBio, Inc.

iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan

NEW YORK, June 08, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“IBIO” OR THE “COMPANY”) announced today that on June 6, 2018, the Company received a letter from NYSE American LLC...